Relmada Therapeutics
RLMD
$0.37
Share price
-8.97%
Change (1 day)
-94.21%
Change (1 year)
Categories
Earnings for Relmada Therapeutics (RLMD)
Earnings in 2024 (TTM): -S$0.12 Billion
According to Relmada Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.14 Billion, an increase over its 2022 earnings that were of -S$0.21 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Relmada Therapeutics from 2012 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -S$0.12 Billion | -12.94% |
| 2023 | -S$0.14 Billion | -37.09% |
| 2022 | -S$0.21 Billion | 24.88% |
| 2021 | -S$0.17 Billion | 111.5% |
| 2020 | -S$79.24 Million | 296.24% |
| 2019 | -S$20 Million | -12.05% |
| 2018 | -S$22.74 Million | 183.21% |
| 2017 | -S$8.03 Million | -23.25% |
| 2016 | -S$10.46 Million | -235.74% |
| 2015 | S$7.7 M | |
| 2013 | -S$0.07 Million | 144.12% |
| 2012 | -S$0.03 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | S$58.27 M | -150.56% | 🇮🇱 Israel |
 | -S$0.79 Billion | 581.63% | 🇺🇸 USA |